Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Boehringer Ingelheim has teamed up with China’s Zhangjiang Biotech & Pharmaceutical Base Development Co. for what it says will be the first plant for drugs based on mammalian cell cultures to be built in China by an international firm. In addition to being a drug company in its own right, Boehringer is a major contract manufacturer of biologic drugs. The German firm says the new plant, to cost more than $45 million, will provide development and clinical services to Chinese and multinational customers.
This article has been sent to the following recipient: